Question

Difficulty: MediumBipolar and Related Disorders

A 28-year-old woman is evaluated in the outpatient psychiatric clinic for maintenance pharmacotherapy following a recent hospitalization for an acute manic episode. Her past psychiatric history includes two prior episodes of major depression. Physical examination is unremarkable, and on mental status examination, her mood is euthymic with normal speech and thought processes. The physician discusses several medication options, emphasizing the importance of specific baseline laboratory testing, adverse effect profiles, and appropriate prescribing practices in bipolar disorder. Match each psychotropic intervention with its characteristic adverse effect profile, required monitoring, or primary clinical risk.

  • LithiumRequires baseline thyroid stimulating hormone and renal function panel due to the risk of tubulointerstitial nephropathy and hypothyroidism.
  • ValproateRequires baseline liver function tests and complete blood count due to the risk of fatal hepatotoxicity, pancreatitis, and thrombocytopenia.
  • LamotrigineRequires no specific baseline laboratory monitoring but necessitates slow dose titration to minimize the risk of Stevens-Johnson syndrome.
  • Sertraline monotherapyStrongly contraindicated as a standalone treatment due to the high risk of precipitating mood destabilization and acute mania.

Answer

Lithium matches with thyroid/renal monitoring; Valproate matches with liver/CBC monitoring; Lamotrigine matches with slow titration for rash risk; Sertraline monotherapy matches with the risk of precipitating acute mania.
Effective pharmacotherapy for bipolar disorder requires careful selection and monitoring of medications. Lithium necessitates renal and thyroid monitoring due to risks of nephropathy and hypothyroidism. Valproate requires hepatic and hematologic monitoring due to risks of hepatotoxicity and thrombocytopenia. Lamotrigine requires slow dose titration to avoid life-threatening Stevens-Johnson syndrome. Crucially, SSRI monotherapy (like sertraline) is contraindicated in bipolar disorder as it can precipitate manic episodes.

Step-by-Step Solution

1
Identify the primary risk of using antidepressant monotherapy (Sertraline) in bipolar disorder.
It carries a high risk of precipitating mania.
Antidepressants without concurrent mood stabilizers can cause mood destabilization in bipolar patients.
2
Determine the baseline monitoring for Lithium.
Baseline TSH and renal function (BUN/creatinine) are needed.
Lithium is associated with hypothyroidism and renal toxicity (tubulointerstitial nephropathy).
3
Determine the baseline monitoring for Valproate.
Baseline LFTs and CBC are needed.
Valproate carries risks of severe hepatotoxicity, pancreatitis, and thrombocytopenia.
4
Determine the monitoring for Lamotrigine.
No specific routine labs, but very slow titration is required.
Lamotrigine is associated with a risk of Stevens-Johnson syndrome, which is dose-dependent.

Key Concept

Pharmacologic management of bipolar disorder, including baseline monitoring for mood stabilizers and the contraindication of antidepressant monotherapy.
Rate this question